|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 7/00 | (2006.01) |
| C07K 16/18 | (2013.01) | ||
| C07K 16/18 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/54 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K2317/92 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Number of the document | 3873602 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19806353.9 |
| Date of filing the European patent application | 2019-10-30 | |
| (97) | Date of publication of the European application | 2021-09-08 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/058846 |
| Date | 2019-10-30 |
| (87) | Number | WO 2020/092549 |
| Date | 2020-05-07 |
| (30) | Number | Date | Country code |
| 201862752563 P | 2018-10-30 | US |
| (72) |
VOLLES, Lori , US
PRADHAN, Rajendra , US
SHERIDAN, Douglas, L. , US
VALLEE, Marc , US
GAO, Xiang , US
|
| (73) |
Alexion Pharmaceuticals, Inc. ,
121 Seaport Boulevard, Boston, MA 02210,
US
|
| (54) | SUBCUTANEOUS DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |
| SUBCUTANEOUS DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) |